2020, Number 1
<< Back Next >>
Revista Cubana de Ortopedia y Traumatología 2020; 34 (1)
Stem cell therapy in osteonecrosis of the femoral head
Núñez CAM, Zavaleta AR
Language: Spanish
References: 28
Page: 1-12
PDF size: 268.91 Kb.
ABSTRACT
Objectives: To describe the therapeutic effect of the stem cell use in managing osteonecrosis of the femoral head.
Methods: A search was carried out in the different databases as Pubmed / MEDLINE, BVS and Cochrane for the last 10 years, including relevant meta-analysis studies, clinical trials and reviews. In addition, the official website of the World Health Organization was checked for additional references. The search words were: “(“ Stem Cells ”OR“ Stem Cell Transplantation ”[Mesh] OR“ Mesenchymal Stem Cell Transplantation ”[Mesh] OR Hematopoietic Stem Cell Transplantation” [Mesh] OR Cell-and Tissue-Based Therapy ”[ Mesh] “Multipotent Stem Cells” [Mesh] OR “Embryonic Stem Cells” [Mesh]) AND (“Osteonecrosis” [Mesh] OR “Femur Head Necrosis” [Mesh] “osteonecrosis of the femoral head” OR "Femoral head"). We include a total of 7 studies, 2 meta-analyzes, 2 review articles, 2 controlled and randomized clinical trials, and one evidence study.
Findings: All the studies showed that stem cell therapy in managing osteonecrosis of the femoral head is safe and effective. The combined treatment of central decompression plus stem cell implantation showed greater effectiveness.
Conclusions: Stem cell therapy is a therapeutic option to treat osteonecrosis of the femoral head, especially in the early stages. The combination of central decompression plus the infiltration of stem cells in the necrotic area produces an improvement in the symptoms and contains the progress of the disease.
REFERENCES
Pepke W, Kasten P, Beckmann NA, Janicki P, Egermann M. Core Decompression and Autologous Bone Marrow Concentrate for Treatment of Femoral Head Osteonecrosis: A Randomized Prospective Study. Orthop Rev (Pavia). 2016 Mar [citado 25 Jun 2020];8(1). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821226/
Im GI. Clinical use of stem cells in orthopaedics. Eur Cell Mater. 2017;33:183-96.
Kolios G, Moodley Y. Introduction to Stem Cells and Regenerative Medicine. RES. 2013;85(1):3-10.
Narayanan A, Khanchandani P, Borkar RM, Ambati CR, Roy A, Han X, et al. Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization. Sci Rep. 2017 Sep [citado 21 Jun 2020];7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587540/
Barney J, Piuzzi NS, Akhondi H. Femoral Head Avascular Necrosis. En: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 [citado 21 Jun 2020]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK546658/
Adesina O, Brunson A, Keegan THM, Wun T. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California. Blood Adv. 2017 Jul;1(16):1287-95.
Jaffré C, Rochefort GY. Alcohol-induced Osteonecrosis – dose and duration effects. Int J Exp Pathol. 2012 Feb;93(1):78-9.
Vardhan H, Tripathy SK, Sen RK, Aggarwal S, Goyal T. Epidemiological Profile of Femoral Head Osteonecrosis in the North Indian Population. Indian J Orthop. 2018;52(2):140-6.
Ikeuchi K, Hasegawa Y, Seki T, Takegami Y, Amano T, Ishiguro N. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan. Mod Rheumatol. 2015 Mar;25(2):278-81.
Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. 2019 Mar;4(3):85-97.
Rego P, Mascarenhas V, Collado D, Coelho A, Barbosa L, Ganz R. Arterial Topographic Anatomy Near the Femoral Head-Neck Perforation with Surgical Relevance. J Bone Joint Surg Am. 2017 Jul;99(14):1213-21.
Arbab D, König DP. Atraumatic Femoral Head Necrosis in Adults. Dtsch Arztebl Int. 2016 Ene;13(3):31-8.
Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015 Sep;6(8):590-601.
Kawano K, Motomura G, Ikemura S, Kubo Y, Fukushi J, Hamai S, et al. Long-term hip survival and factors influencing patient-reported outcomes after transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head: A minimum 10-year follow-up case series. Mod Rheumatol. 2020 Ene;30(1):184-90.
Suksathien Y, Sueajui J. Mid-term results of short stem total hip arthroplasty in patients with osteonecrosis of the femoral head. Hip Int. 2019 Nov;29(6):603-8.
Ünal MB, Cansu E, Parmaksızoğlu F, Cift H, Gürcan S. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting: Results of 7.6-year follow-up. Acta Orthop Traumatol Turc. 2016 Oct;50(5):501-6.
Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019 Feb [citado 19 Jun 2020];10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390367/
Efthymiou AG, Chen G, Rao M, Chen G, Boehm M. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. Expert Opin Biol Ther. 2014 Sep;14(9):1333-44.
Wagers AJ. The stem cell niche in regenerative medicine. Cell Stem Cell. 2012 Abr;10(4):362-9.
Aoyama T, Goto K, Kakinoki R, Ikeguchi R, Ueda M, Kasai Y, et al. An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev. 2014 Ago;20(4):233-42.
Daltro GC, Fortuna V, de Souza ES, Salles MM, Carreira AC, Meyer R, et al. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther. 2015 May;6:110.
Wang Z, Sun Q-M, Zhang F-Q, Zhang Q-L, Wang L-G, Wang W-J. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis. Int J Surg. 2019 Sep;69:23-31.
Andriolo L, Merli G, Tobar C, Altamura SA, Kon E, Filardo G. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42(7):1689-704.
Zhao L, Kaye AD, Kaye AJ, Abd-Elsayed A. Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review. Curr Pain Headache Rep. 2018 May;22(6):41.
Li R, Lin Q-X, Liang X-Z, Liu G-B, Tang H, Wang Y, et al. Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research. Stem Cell Res Ther. 2018 Oct [citado 25 Jun 2020];9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202807/
Mardones R, Camacho D, Monsalvo F, Zulch N, Jofre C, Minguell JJ. Treatment of osteonecrosis of the femoral head by core decompression and implantation of fully functional ex vivo-expanded bone marrow-derived mesenchymal stem cells: a proof-of-concept study. Stem Cells Cloning. 2019 Mar;12:11-6.
Mao Q, Wang W, Xu T, Zhang S, Xiao L, Chen D, et al. Combination Treatment of Biomechanical Support and Targeted Intra-arterial Infusion of Peripheral Blood Stem Cells mobilized by granulocyte-colony stimulating factor for the Osteonecrosis of the Femoral Head: a randomised controlled clinical trial. J Bone Miner Res. 2015 Abr;30(4):647-56.
Lim YW, Kim YS, Lee JW, Kwon SY. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013 Nov;45(11):e61.